Pulse Biosciences Inc
PLSE
Market Cap$979.42M
Close$
$1.87
87.8% downside
Current Fair Value
87.8% downsideOvervalued by 87.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $979.42 Million |
|---|---|
| Enterprise Value | $871.09 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.88 |
| Beta | 1.74 |
| Outstanding Shares | 57,180,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -20.76 |
|---|---|
| PEG | -31.6 |
| Price to Sales | - |
| Price to Book Ratio | 7.65 |
| Enterprise Value to Revenue | 1046.98 |
| Enterprise Value to EBIT | -13.68 |
| Enterprise Value to Net Income | -15 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.09 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Pulse Biosciences Inc
95 employeesPulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve the quality of life for patients. The CellFX® System is the first commercial product to harness the distinctive ad...